The Global Asthma Diagnostics Market was valued at US$ 3,385.5 Mn in 2021 and is forecasted to reach US$ 5,857.7 Mn by 2030, registering a CAGR of 6.5% over the projection period.
The study undertaken by Astute Analytica forecasts growth in revenue of the Global Diagnostics Market from US$ 7,320.6 Mn in 2021 to US$ 12,159.8 Mn by 2030. The diagnostics market study examines tuberculosis, asthma, sepsis, and pneumonia diagnostics market for the study period 2017-2030.
Request Brochure of Report - https://www.astuteanalytica.com/request-sample/diagnostics-market
Market Snapshot:
The Global Tuberculosis Diagnostics Market is estimated to reach US$ 4,480.7 Mn by 2030 from US$ 2,984.8 Mn in 2021, registering a CAGR of 4.7% during 2022-2030.
The Global Asthma Diagnostics Market was valued at US$ 3,385.5 Mn in 2021 and is forecasted to reach US$ 5,857.7 Mn by 2030, registering a CAGR of 6.5% over the projection period.
The Global Sepsis Diagnostics Market is witnessing a CAGR of 8.4% during 2022-2030. The Sepsis Diagnostics Market is projected to witness a growth in its revenue from US$ 489.3 Mn in 2021 to US$ 992.8 Mn by 2030.
The Global Pneumonia Diagnostics Market is anticipated to experience a leap forward in its revenue from US$ 460.9 Mn in 2021 to US$ 828.5 Mn by 2030, recording a growth rate of 6.9% over the forecast period.
The market is majorly driven by factors such as an increase in the prevalence of chronic and infectious diseases and the availability of point-of-care testing kits. Infectious diseases are on the rise across the world. According to WHO (World Health Organization), a total of 1.5 million people died from TB in 2020. Worldwide, TB is the 13th leading cause of death and the second leading infectious killer after COVID-19. TB occurs in every part of the world. In 2020, the largest number of new TB cases occurred in the WHO South-East Asian Region, with 43% of new cases, followed by the WHO African Region, with 25% of new cases. Further, asthma is a major non-communicable disease affecting both children and adults. According to the data presented by WHO, asthma affected an estimated 262 million people in 2019 and caused 4,55,000 deaths. Sepsis is a syndromic response to infection and is frequently a final common pathway to death from many infectious diseases worldwide. According to recent studies, sepsis kills 11 million people each year, many of them children. It disables millions more. In addition, Pneumonia is the single largest infectious cause of death in children worldwide. Pneumonia accounts for 14% of all deaths of children under 5 years old in 2019. Moreover, the availability of point of care testing kits such as lateral flow assays is propelling the market growth. However, stringent regulatory approvals may affect market growth.
Regional Analysis of the Global Tuberculosis Diagnostics Market
Asia Pacific holds the highest share of the Global Tuberculosis Diagnostics Market and registers the highest CAGR over the forecast period. This is because the Asia-Pacific region carries the highest share of the global TB burden, including the majority of all estimated multidrug-resistant (MDR)-TB cases. India is the highest shareholder country in the region which also registers the highest CAGR over the projection period. Further, in Europe, the UK is the highest shareholder country in 2021. South Africa holds the majority of the share in the Middle East & Africa tuberculosis diagnostics market.
Regional Analysis of the Global Asthma Diagnostics Market
Asia Pacific is the highest shareholder region in the Global Asthma Diagnostics Market in 2021. Further, India is the highest shareholder country in the region and registers the highest CAGR over the forecast period. The US is the highest shareholder country in the North America asthma diagnostics market. Brazil dominates the South America asthma diagnostics market in 2021.
Regional Analysis of the Global Sepsis Diagnostics Market
North America is the highest shareholder region in the Global Sepsis Diagnostics Market in 2021. The US is the highest shareholder country in the region in 2021 and further registers the highest CAGR over the forecast period. Asia Pacific records the highest CAGR over the forecast period. This is because in low- and middle-income countries sepsis represents a major cause of maternal and neonatal morbidity and mortality.
Regional Analysis of the Global Sepsis Diagnostics Market
North America holds the highest market share in 2021. The US is the highest shareholder country in the pneumonia diagnostic market in 2021. Further, Asia Pacific registers the highest CAGR over the projection period. In Europe, the UK registers the highest market share and France holds the highest annual growth rate over the forecast period.
Competitive Insights
- Abbott has businesses and products in diagnostics, medical equipment, nutritional, and branded generic medications, and its portfolio of life-changing technology spans the healthcare spectrum.
- Becton, Dickinson and Company or BD, is an American multinational medical technology firm that is involved in the manufacturing and selling of medical devices, instrument systems, and reagents.
- BioMérieux is a company in the field of in-vitro diagnostics. The clinical application includes immunoassay, mirobiology, molecular diagnostics, lab automation, lab consultancy, and other services.
- Luminex Corporation develops, manufactures, and markets biological testing technologies with applications throughout the clinical diagnostic and life science industries. The Company develops open-architecture technologies that enable large numbers of biological tests bioassays to be conducted and analyzed quickly and accurately.
- Quest Diagnostics provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
Segmentation Overview
The following are the various segmentation of the Global Diagnostics Market:
- Global Tuberculosis Diagnostics Market
- By Test Type segment of the Global Tuberculosis Diagnostics Market is sub-segmented into:
-
- Radiographic Method
- Cytokine Detection Assay
- Nucleic Acid Testing
- Detection of Latent Infection
- Diagnostic Laboratory Method
- Detection of Drug Resistance
- Others
-
- By End User segment of the Global Tuberculosis Diagnostics Market is sub-segmented into:
-
- Clinics
- Hospitals
- Research Institutes & Academics
- Diagnostic Centers
-
- Global Asthma Diagnostics Market
- By Test Type segment of the Global Asthma Diagnostics Market is sub-segmented into:
-
- Radiographic Method
- Spirometry Test
- Bronchodilator Reversibility Test
- FeNO Test
- Peak Flow
- Bronchial Challenge Tests
- Allergy tests
- Others
-
- By End User segment of the Global Asthma Diagnostics Market is sub-segmented into:
-
- Clinics
- Hospitals
- Research Institutes & Academics
- Diagnostic Centers
-
- Global Sepsis Diagnostics Market
- By Test Type segment of the Global Sepsis Diagnostics Market is sub-segmented into:
-
- CRP Test
- PT & PTT Test
- Urinalysis
- Pulse Oximetry
- Others
-
- By End User segment of the Global Sepsis Diagnostics Market is sub-segmented into:
-
- Clinics
- Hospitals
- Research Institutes & Academics
- Diagnostic Centers
-
- Global Pneumonia Diagnostics Market
- By Test Type segment of the Global Pneumonia Diagnostics Market is sub-segmented into:
-
- Blood Test
- Chest X-Ray Test
- Pulse Oximetry
- Sputum Test
- Others
-
- By End User segment of the Global Pneumonia Diagnostics Market is sub-segmented into:
-
- Clinics
- Hospitals
- Research Institutes & Academics
- Diagnostic Centers
-
Read More – https://www.astuteanalytica.com/industry-report/diagnostics-market
For Additional Information OR Media Enquiry, Please Mail Us At: sales@astuteanalytica.com
About Astute Analytica
Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
Contact us:
Aamir Beg BSI Business Park, H-15,Sector-63, Noida- 201301- India
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
Email: sales@astuteanalytica.com
Website: www.astuteanalytica.com
Follow US: LinkedIn | Twitter